The Effects of Repeated Operational Stress and Limited Recovery on Resilience Capacity
REP DEF
2 other identifiers
interventional
24
1 country
1
Brief Summary
This longitudinal study will examine the effects of repeated bouts of operational stress and limited recovery on integrated MPS, whole-body protein balance, iron absorption, and aerobic performance. Following baseline characterization measures, active adults (n=24) representative of normal weight phenotype (NW; n=12) and overweight phenotype (OW; n=12) will complete a 48h balance phase preceding two rounds of repeated 72h energy deficit exposure each immediately followed by a 48h recovery phase. NW cutoff will be defined ≤ 22% body fat for males and ≤ 32% body fat for females. OW cutoff will be defined as \>22% body fat for males and \>32% body fat for females. These body composition cutoffs are informed by the maximum allowable percent body fat standards outlined in current Army Regulation 600-9. Additional details for determining % body fat are outlined in the experimental procedures section of the protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedJanuary 20, 2025
January 1, 2025
6 months
January 14, 2025
January 14, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Integrated muscle protein synthesis
deuterium oxide stable isotope
Days 1-13
Whole-body protein balance
15N alanine stable isotope
24 hours
Iron Absorption
57-Fe dissolved in water
24 hours
Study Arms (2)
Active adults representative of overweight phenotype
EXPERIMENTALActive adults representative of overweight phenotype will complete a 48h balance phase followed by two rounds of repeated 72h energy deficit exposure, each immediately followed by a 48h recovery phase.
Active adults representative of normal weight phenotype
ACTIVE COMPARATORActive adults representative of normal weight phenotype will complete a 48h balance phase followed by two rounds of repeated 72h energy deficit exposure, each immediately followed by a 48h recovery phase.
Interventions
Intervention consists of a 48 hour energy balance phase preceding two rounds of repeated 72 hour energy deficit exposure each immediately followed by a 48h recovery phase. Balance and recovery phases will meet 100% of baseline energy requirements. Energy deficit phases will include an approximate 60% energy deficit of total daily energy requirements achieved through both a reduction in dietary intake and increased energy expenditure through physical activity.
Eligibility Criteria
You may qualify if:
- Men and women aged 18 - 39 years (17 - 39 years if military personnel)
- Weight stable in the past 2 months (± approximately 5 kg)
- Healthy without evidence of chronic illness or musculoskeletal injury as determined by the USARIEM Office of Medical Support and Oversight (OMSO) or home duty station medical support (HMS)
- Functional exercise (i.e., step ups, box jumps, body mass movements) and/or aerobic exercise trained defined by self-report as performing ≥ 2 sessions/wk for previous 6 months
- Willing to refrain from alcohol, smoking any nicotine product (includes e-cigarettes); vaping, chewing tobacco, caffeine not provided in the study, and dietary supplement use throughout the dietary interventions
- Biological females must be on sustained (i.e., approximately \>3 months) oral/hormonal contraceptive use which acts to maintain continuous hormonal levels (i.e., contains low-dose estrogen/progesterone with no oral placebos, hormonal IUD)
- Supervisor approval for federal civilian employees and non-HRV active duty military personnel)
You may not qualify if:
- Musculoskeletal injuries that compromise exercise capability as determined by OMSO or HMS
- Metabolic or cardiovascular abnormalities, sleep disorders (i.e., sleep apnea) gastrointestinal disorders (e.g., kidney disease, diabetes, cardiovascular disease, etc.) as determined by OMSO or HMS
- Abnormal or problems with blood clotting as determined by OMSO or HMS
- History of complications with lidocaine or similar local anesthetic analogue
- Present condition of alcoholism, anabolic steroids, or other substance abuse issues
- Blood donation within 8-wk of beginning or completing study blood draws
- Current diagnosis of Anemia (hemoglobin \< 13 g/dL for males, hemoglobin \< 12 g/dL for females) and Sickle Cell Anemia/Trait as determined by OMSO or HMS
- Pregnant, trying to become pregnant, and/or breastfeeding (results of urine pregnancy test or self-report for breastfeeding will be obtained before body composition testing)
- Claustrophobia or discomfort related to having enclosed equipment around the head
- Unwillingness or inability to consume study diets or foods provided due to personal preference or food allergies/sensitivities
- Unwillingness or inability to adhere to study exercise restrictions and prescriptions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
US Army Research Institute of Environmental Medicine
Natick, Massachusetts, 01760, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jess A Gwin Principal Investigator, PhD
United States Army Research Institute of Environmental Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2025
First Posted
January 20, 2025
Study Start
May 1, 2025
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
January 20, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared.